Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov;21(11):2453-2461.
doi: 10.1038/s41436-019-0516-z. Epub 2019 Apr 17.

Aberrant DNA methylation as a diagnostic biomarker of diabetic embryopathy

Katharina V Schulze  1 , Amit Bhatt  2 , Mahshid S Azamian  1 , Nathan C Sundgren  2 , Gladys E Zapata  2 , Patricia Hernandez  2 , Karin Fox  1   3 , Jeffrey R Kaiser  2   3 , John W Belmont  1   2   4 , Neil A Hanchard  5   6
Affiliations
Free article

Aberrant DNA methylation as a diagnostic biomarker of diabetic embryopathy

Katharina V Schulze et al. Genet Med. 2019 Nov.
Free article

Abstract

Purpose: Maternal diabetes is a known teratogen that can cause a wide spectrum of birth defects, collectively referred to as diabetic embryopathy (DE). However, the pathogenic mechanisms underlying DE remain uncertain and there are no definitive tests to establish the diagnosis. Here, we explore the potential of DNA methylation as a diagnostic biomarker for DE and to inform disease pathogenesis.

Methods: Bisulfite sequencing was used to identify gene regions with differential methylation between DE neonates and healthy infants born with or without prenatal exposure to maternal diabetes, and to investigate the role of allele-specific methylation at implicated sites.

Results: We identified a methylation signature consisting of 237 differentially methylated loci that distinguished infants with DE from control infants. These loci were found proximal to genes associated with Mendelian syndromes that overlap the DE phenotype (e.g., CACNA1C, TRIO, ANKRD11) or genes known to influence embryonic development (e.g., BRAX1, RASA3). Further, we identified allele-specific methylation (ASM) at 11 of these loci, within which 61.5% of ASM single-nucleotide variants are known expression quantitative trait loci (eQTLs).

Conclusions: Our study suggests a role for aberrant DNA methylation and cis-sequence variation in the pathogenesis of DE and highlights the diagnostic potential of DNA methylation for teratogenic birth defects.

Keywords: allele-specific methylation; bisulfite sequencing; diabetic embryopathy; infant of a diabetic mother; teratogens.

PubMed Disclaimer

References

    1. Sheffield JS, Butler-Koster EL, Casey BM, McIntire DD, Leveno KJ. Maternal diabetes mellitus and infant malformations. Obstet Gynecol. 2002;100:925–930. - PubMed
    1. Sharpe PB, Chan A, Haan EA, Hiller JE. Maternal diabetes and congenital anomalies in South Australia 1986-2000: a population-based cohort study. Birth Defects Res A Clin Mol Teratol. 2005;73:605–611. - DOI
    1. Garcia-Patterson A, et al. In human gestational diabetes mellitus congenital malformations are related to pre-pregnancy body mass index and to severity of diabetes. Diabetologia. 2004;47:509–514. - DOI
    1. Schaefer-Graf UM, et al. Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol. 2000;182:313–320. - DOI
    1. Dominguez-Salas P, et al. Maternal nutrition at conception modulates DNA methylation of human metastable epialleles. Nat Commun. 2014;5:3746. - DOI

Publication types

LinkOut - more resources